Delivery Order SPE2DB25D3404-SPE2DB25FUQPT
- Not listed
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on October 21, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. The contract was competitively awarded without set-aside designation and carries a completion date of October 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and military healthcare systems through its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. The contract, issued on July 29, 2025, with a completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a $24,661.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on September 18, 2025, with an ultimate completion date of October 9, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively procured...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 12, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector pharmaceutical product. This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and was competitively awarded with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA, leveraging the company's established...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, valued at $12,330.68 for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside delivery order with a completion deadline of September 8, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, non-set-aside contract was finalized on July 31, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract utilizes firm fixed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 24, 2025, with an ultimate completion date of October 16, 2025. This is a firm fixed price, non-set-aside delivery order performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQPTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure with an ultimate completion date of October 14, 2025. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, continues to serve as a critical vendor for federal military and veteran healthcare supply chains through this comprehensive pharmaceutical support vehicle. The IDC enables the company to distribute a broad portfolio of pharmaceutical products, vaccines, medical devices, and specialty medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major for-profit pharmaceutical distributor with established capabilities in federal procurement, AmerisourceBergen maintains a consistent track record of fulfilling competitive federal medical supply contracts ranging from modest transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/22/25 |